Purpose

The Sources page explains how USChinaHealthcare.com uses source families. It is organized around evidence families rather than exhaustive citation lists. It relies on official agencies for rules, statistical agencies for data, peer-reviewed literature for evidence, professional sources for implementation context, and strategy interpretation for cross-border implications.

Plain-English answer

The Sources page explains how USChinaHealthcare.com uses source families. It is organized around evidence families rather than exhaustive citation lists. It relies on official agencies for rules, statistical agencies for data, peer-reviewed literature for evidence, professional sources for implementation context, and strategy interpretation for cross-border implications.

How to use this reference

Editorial method and evidence use: Sources is a practical editorial reference, not a market thesis. The Sources page explains how USChinaHealthcare.com uses source families. It is organized around evidence families rather than exhaustive citation lists. It relies on official agencies for rules, statistical agencies for data, peer-reviewed literature for evidence, professional sources for implementation context, and strategy interpretation for cross-border implications. The page’s primary lens is source families and evidence context. Avoidable error: Treating all sources as equal because they are online.

Concretely, use this page to decide what kind of evidence a claim needs: official policy text, administrative data, peer-reviewed research, field evidence, historical context, or strategic inference. The aim is disciplined judgment: enough sourcing to make the reasoning transparent, without turning every explanatory page into a citation ledger.

How this page should be used

These methods pages explain the editorial standards behind source selection, evidence grading, terminology, Chinese-language access, and preservation of historical material.

MechanismSource choice depends on the claim type. A regulatory claim should use agency material. A data claim should use the relevant statistical source. A market-entry claim may require official sources plus interviews, payer policies, procurement documents, and commercial diligence.
Decision useReaders should treat the source guidance as a map of evidence families, not as a substitute for judgment about context, authority, and applicability.
Evidence logicThe strongest pages separate stable institutional mechanisms from volatile implementation details and flag which source family should be checked before publication or client use.

Operating mechanism

Source choice depends on the claim type. A regulatory claim should use agency material. A data claim should use the relevant statistical source. A market-entry claim may require official sources plus interviews, payer policies, procurement documents, and commercial diligence.

Decision rule

Readers should treat the source guidance as a map of evidence families, not as a substitute for judgment about context, authority, and applicability.

Evidence and source logic

The strongest pages separate stable institutional mechanisms from volatile implementation details and flag which source family should be checked before publication or client use.

Core sections

Official policy and regulatory sources

Method note

CMS, FDA, HHS, ONC, NHC, NHSA, NMPA, State Council, China CDC, and provincial or local implementing bodies.

Statistical and administrative sources

Method note

CMS National Health Expenditure, Census, OECD, WHO, NHSA statistics, NHC statistical yearbooks, and disease registries where appropriate.

Peer-reviewed and professional sources

Method note

Health policy journals, health-services research, specialty society materials, hospital operations literature, and regulatory science articles.

Commercial and field sources

Method note

Payer policies, procurement documents, interviews, account-level diligence, investor materials, tender data, and partner documentation.

Implementation checklist

CheckReasonFailure mode
Does the page have a clear parent hub?Readers need a clear path from broad hubs to specific topics.Orphan pages that crawlers and readers cannot interpret.
Does the source family match the claim?Regulatory, data, clinical, and strategy claims require different sources.Overconfident pages built on weak source fit.
Does the page avoid public date-label clutter?Current content should not be made artificially stale.Stable explanations that look obsolete because of visible metadata.

Method pitfall

Treating all sources as equal because they are online. A stronger approach is to connect content structure, source logic, and internal links before expanding page count.

Reference guides

Indices, FAQs, agency glossary, and timelines

These pages provide concise entry points into system, hospital, province, insurance, reform, TCM, population health, medtech, biopharma, digital health, market entry, regulatory, Chinese reader, FAQ, agency, and timeline topics.

Health Systems Indexsystem-level pages across U.S., China, and comparisons China Hospitals Directoryhospital architecture and hospital-related pages China Provinces Healthcare Indexprovince and region healthcare profiles China Health Insurance DirectoryChina insurance, financing, reimbursement, and payment pages China Healthcare Reform Directoryreform briefs and policy instruments Traditional Chinese Medicine DirectoryTCM history, regulation, institutions, and debate Population Health in China Indexhealth indicators and disease-burden pages Medtech Indexdevice, diagnostic, procurement, and channel pages Biopharma Indexdrug, trial, supply chain, and licensing pages Digital Health and AI Indexdigital health, AI, data, and cybersecurity pages Market Entry IndexU.S.-to-China and China-to-U.S. strategy pages Regulatory Pathways IndexFDA, NMPA, trial, device, drug, and diagnostic pathway pages U.S. Healthcare for Chinese Readers IndexChinese-language and U.S. system pages for Chinese readers U.S.-China Healthcare FAQtop-level comparison questions China Healthcare FAQChinese healthcare system questions U.S. Market Entry FAQ for Chinese Healthcare CompaniesChina-to-U.S. commercialization Common Mistakes in U.S.-China Healthcare Comparisonsfalse equivalences and generic comparison mistakes Glossary of Chinese Healthcare Agenciesagency-specific glossary and index Timeline of Chinese Healthcare Reformchronological reform spine linking reform pages Timeline of U.S.-China Healthcare Relationshistorical relationship without daily-news framing